Low T: Disease, the Gold Mine

Retsinas, Joan
December 2013
Progressive Populist;12/1/2013, Vol. 19 Issue 21, p15
The author details how the pharmaceutical industry and some entrepreneurs earn large profits by inventing a disease and developing a cure for it, citing low-testosterone as an example, with marketers convincing men that they must boost their testosterone levels in spite of a lack of medical data.


Related Articles

  • WHY DRUG COMPANIES ARE THE MOST PROFITABLE U.S. INDUSTRY.  // Health & Stress;2003, Issue 2, p1 

    Reports that pharmaceutical companies continued their supremacy as the most profitable industry the United States in 2001. Profits earned by Fortune 500 pharmaceutical companies; Shift to more expensive prescriptions; Factors that have allowed drug companies to gain substantial profits.

  • Old Copycats: Learn New Tricks. Desai, V. Subhash // Siliconindia;Mar2002, Vol. 6 Issue 3, p10 

    Focuses on the aspects of the pharmaceutical industry in India. Overview on the average profits and revenues of pharmaceutical companies; Complexities facing large and small pharmaceutical firms; Profitability and risks with drug discovery.

  • IMS Health Business Watch. Friedman, Katherine; Kulp, Katrina // Medical Marketing & Media;May2000, Vol. 35 Issue 5, p40 

    Reports on the increase in the sales for the United States pharmaceutical industry for the year 1999. Increase in sales due to increased use of medicine; Anti-ulcer drugs' domination of the market; Percentage of drug purchases from retail pharmacies.

  • Key pharmaceutical markets expect growth through 2005.  // Fairfield County Business Journal;04/16/2001, Vol. 40 Issue 16, p25 

    Focuses on the expected growth of pharmaceutical markets in Latin America. Average rate of sales expansion; Expected annual sales in Mexico; Factors affecting the pharmaceutical industry; Influence of currency changes on pharmaceutical sales; Projected healthcare market status.

  • Drug Industry Most Profitable.  // HealthFacts;May2002, Vol. 27 Issue 5, p3 

    Reports on the profitability of the drug industry in the U.S., according to the organization FamiliesUSA.

  • Big Pharma Pursues Top Position in Japanese Market. Jarvis, Lisa // Chemical Market Reporter;10/7/2002, Vol. 262 Issue 12, p10 

    Presents top ten Japanese pharmaceutical companies forecasts for the year 2002. List of small companies that needed mergers; Total revenues generated by the companies; Issuance of bold objectives for penetration of pharmaceutical companies in the U.S. market.

  • Drug Chain Annual Report.  // Drug Store News;4/28/2003, Vol. 25 Issue 6, p1 

    Reports on the profit performance of the pharmaceutical industry in the U.S.

  • Hungary Egis, Richter to release Q412 earnings figures.  // Hungary A.M.;02/04/2013, p2 

    The article reports on the projected substantial net profit increase of Hungarian pharmaceutical producers in the fourth quarter of 2012.

  • Pharmaceutical companies' 2Q earnings are a mixed bag. Martinez, Marialba // Caribbean Business;8/8/2002, Vol. 30 Issue 32, p14 

    Reports on the financial performance of U.S. pharmaceutical companies during the second quarter of 2002. Sales of Pharmacia Corp.; Net income of Wyeth; Key growth-driver products for Abbott Laboratories; Product sales of Bristol-Myers Squibb Co.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics